Joe Swedish, a career hospital executive, is now two months into his job at the helm of Indianapolis-based WellPoint, the nation’s second-largest health insurer. In his first interview since starting work, Swedish indicated he’s taking his time to learn the people and the culture of the vast organization he now leads.
With premiums for health insurance likely to head north next year as President Obama’s health care reform law fully takes effect, both individuals and employers will pay for more health care out of their own funds and buy less insurance.
The study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare to pay for use of its brain imaging agent Amyvid.
Greenwood officials three years ago approved $8.4 million of incentives for the Elona Biotechnologies project, including the construction loan.
Eli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major developed countries.
Roche Diagnostics Corp. is considering a sale of its blood-glucose meter business, a move that would cast uncertainty over the nearly 1,000 people working for its diabetes business in Indianapolis.
George Bowman, 43, and Traci L. Bowman, 42, are accused of falsifying purchase records and fraudulently filing insurance claims for expensive construction equipment they never purchased.
The future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source: smartphone apps.
Outside observers cast the departures of Lenox Baker, Sheila Burke and Susan Bayh as a positive that will allow new CEO Joseph Swedish to recast the board.
Eli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta is functioning as intended, the Indianapolis-based drugmaker said.
Lenox Baker, Sheila Burke and Susan Bayh resigned from the board effective immediately, Indianapolis-based WellPoint said Monday in a regulatory filing.
Dr. Jay Hess was picked to become the 10th dean in the school of medicine’s 110-year history and the first dean in the past five to come from outside IU.
The state’s medical-device companies are finding that they cannot pass on the new medical-device tax created by Obamacare to their hospital customers, causing them to continue to make cuts and to look to foreign markets for more profitable growth.
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across the country have been raising prices just because they can, according to a new study.
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues of venture capital, digital health innovations and research university entrepreneurship.
Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
The drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual sales by 2018.
The 133 full-time jobs the truck and auto insurer plans to add over the next five years will pay around $60 an hour, or nearly $125,000 a year.
A federal bankruptcy judge has slapped down an Anderson church that attempted to blame its bank for a failed scheme to finance church upgrades by buying life insurance policies on its elderly members.
Warner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding after numerous complaints against the company went unresolved.
The appointment is the first high-profile post that Braly, 51, has accepted since she was ousted from the top spot at the Indianapolis-based health insurer in August.
